Showing results (11-20 of 207) with videos related to
Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2023
The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus ComplexJohn P O'Donnell, Sujata M BhavnaniCurrent Opinion in Microbiology|October 26, 2000
New agents for Gram-positive bacteriaS M Bhavnani, C H BallowDiagnostic Microbiology and Infectious Disease|September 25, 2007
Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumoniaSujata M Bhavnani, Paul G AmbroseJournal of the Pediatric Infectious Diseases Society|September 16, 2022
Historical Perspective of Pediatric Health Disparities in Infectious Diseases: Centuries in the MakingMatthew P Kronman, Jessica N SnowdenJournal of Neuroimmunology|August 27, 2014
Ventricular shunt infections: immunopathogenesis and clinical managementYenis Gutierrez-Murgas, Jessica N SnowdenClinical and Laboratory Haematology|February 10, 1999
Laboratory control of oral anticoagulant therapy: preservation of prothrombin time specimens using a polypropylene collection systemJ Ridyard, M Bhavnani, L H SealCurrent Opinion in Pharmacology|November 13, 2017
Use of Monte Carlo simulation and considerations for PK-PD targets to support antibacterial dose selectionMichael Trang, Michael N Dudley, Sujata M BhavnaniArthritis and Rheumatism|July 1, 1997
T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controlsN Snowden, I Reynolds, K Morgan, et al.Scandinavian Journal of Rheumatology|January 1, 1993
IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseasesA L Cooper, N Snowden, D E WoolleyThe Annals of Pharmacotherapy|March 16, 2002
Pharmacodynamics in the evaluation of drug regimensSujata M Bhavnani, Paul G Ambrose, Ronald N JonesPageof 21